肝母细胞瘤切除标本病理报告:ICCR国际共识数据集
肝母细胞瘤是儿童最常见的原发性肝脏恶性肿瘤,发病率全球上升。ICCR召集国际专家小组,基于现有证据制定肝母细胞瘤切除标本病理报告的核心与非核心数据项,经国际公开咨询后定稿并发布于ICCR网站,旨在促进高质量标准化病理报告。
要点
- ICCR发布首个肝母细胞瘤切除标本病理报告国际数据集。
- 数据集含核心与非核心数据项,每项附理由与临床相关性注释。
- 数据集免费公开于ICCR网站,供全球采用以标准化报告。
核心结论
- 这是首个由国际专家小组制定的肝母细胞瘤切除标本报告数据集,旨在促进该罕见儿童肝脏肿瘤的高质量标准化病理报告。
研究设计与样本
- 按照ICCR数据集制定指南,由包括儿童病理学家和儿童肿瘤学家在内的国际专家小组,基于对现有证据的批判性审查和讨论制定核心与非核心数据项。
主要发现
- 专家小组确定了肝母细胞瘤切除标本的核心和非核心数据项,并为每个数据项提供注释,解释选择理由、临床相关性及证据缺乏领域。
关键数值与推荐
- 数据集包含核心和非核心数据项,每个数据项附有注释说明其作为核心或非核心元素的理由、临床相关性及潜在证据缺乏领域。
临床怎么用
- 采用ICCR网站免费提供的肝母细胞瘤数据集,可促进准确报告、增强数据收集一致性,并支持回顾性和前瞻性研究。
局限性
- 原文指出部分数据项存在证据缺乏领域,但未具体说明哪些数据项或缺乏何种证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Hepatoblastoma is the most common primary malignant tumour of the liver diagnosed in children and its incidence is increasing worldwide. Ongoing international clinical trials and scientific collaborative efforts are attempting to standardize the diagnosis, risk stratification and management of young patients diagnosed with this rare cancer, which includes surgical resection of the tumour. Here we report the international consensus-based dataset for the pathology reporting of hepatoblastoma resection specimens. The dataset was developed under the auspices of the International Collaboration on Cancer Reporting (ICCR), a global alliance of international pathology and cancer organizations. METHODS AND RESULTS: According to the ICCR's guidelines for dataset development, an international expert panel including paediatric pathologists and a paediatric oncologist specialized in liver tumours developed a set of core and non-core data items for hepatoblastoma resection specimens based on critical review and discussion of current evidence available. Members of the panel were specialists working in tertiary paediatric hospitals, central reviewers for international paediatric liver tumours consortia and/or involved in paediatric liver tumour trials expert committees. Commentaries were provided to support each data item, explaining the rationale for selecting them as a 'core' or 'non-core' elements, their clinical relevance and highlighting potential areas of lack of evidence, including clinical, macroscopic, microscopic and ancillary testing considerations. The hepatoblastoma dataset was finalized and ratified following international public consultation and is published on the ICCR website for wide implementation. CONCLUSION: This is the first international dataset developed by an international expert panel for reporting hepatoblastoma resection specimens aimed to promote high-quality, standardized pathology reporting of these rare paediatric liver tumours. The adoption and implementation of this hepatoblastoma data set, freely available worldwide on the ICCR website (www.iccr-cancer.org/data-sets), will facilitate accurate reporting and enhance the consistency of data collection, support retrospective and inform prospective research and ultimately help to improve clinical outcomes of children with hepatoblastoma.
引用
- López-Terrada DH, Webster F, Alaggio R, et al. Pathology reporting of hepatoblastoma resections: recommendations from the international collaboration on cancer reporting. Histopathology. 2025. PMID: 40831403. doi:10.1111/his.15536
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。